Scientists move a step closer to advancing personalized cancer treatment


In a step likely to advance personalized cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.

Study provides insight into the natural course of COVID-19 infection in pregnancy

Previous article

Ultrapotent IgM antibodies isolated from a pregnant woman with Zika virus show promise as an immunotherapy

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News